Tag Archives: MCI-Screen

Cognitive Screening & Testing Report Released

Computerized Cognitive Assessment Products – Neurocognitive Screening for ADHD, Memory Loss, Alzheimer’s, Dementia, Traumatic Brain Injury Since our last report in 2011, the market for computerized cognitive assessment, screening and testing has continued to expand. Key drivers for this market and growing technology product base include: An Aging Global Population: 500 million people in the […]

Early Detection Tests for Alzheimer’s Disease: Introduction

Rising Dementia Rates are a Global Health Trend A positive aspect of rising living standards in most of the world has been a significant improvement in worldwide average life expectancies, increasing from 52 years in 1960 to 69 years in 2009. Regional differences are even more striking — the average life expectancy for a person […]

Is the Amyloid Hypothesis Dead Wrong?

After the disaster known as bapineuzumab Phase III, I think it’s time to seriously question whether clearing amyloid beta deposits from the brain has any therapeutic benefit to Alzheimer’s patients. The bapi Phase III results speak with a resounding “No”. We are still awaiting Phase III results from Eli Lilly’s solanezumab, but the current prognosis […]

Detecting Alzheimer’s Disease 20 Years Before Symptoms Appear

A research team at Washington University School of Medicine just published the results of a study that looked at a number of cognitive changes and biomarkers that can be used to predict the risk of Alzheimer’s Disease long before symptoms appear – in some cases up to 20 years before symptom onset. The study, published […]

CANTABMobile for Memory and Dementia Screening

Cambridge Cognition announced the general release of a new iPad application for the detection of early memory impairment that is common in Alzheimer’s disease and other forms of dementia. As we reported last September, the iPad application (named CANTABmobile) is based on the Cantab PAL test, a visual working memory test. The CANTABmobile memory test […]

Testing for Mild Cognitive Impairment (MCI)

What is Mild Cognitive Impairment? Mild Cognitive Impairment, or MCI, is an intermediate stage condition between normal cognitive functioning and Alzheimer’s disease or other types of dementia: Signs of MCI include a “change in cognition” — this typically means memory problems, but it can also include planning and reasoning skills that could negatively affect higher […]

Early Screening and Diagnosis of Alzheimer’s is key part of NAPA 2025

The U.S. Department of Health and Human Services (HHS) released a draft road map on February 22 that lays out the national strategy to address the rapidly rising rates of Alzheimer’s disease and other types of dementia. There are over 5.4 Million people in the US living with dementia today, and this is expected to […]

Cognitive Decline at 45: Fact or Fiction?

Several news stories have appeared in the past month regarding this research study, based on the Whitehall II cohort project, which has followed the overall health of several thousand British civil servants since 1985. Most of the news stories use mildly alarmist terms like “Mental Decline Starts at 45” and “Sorry, Boomers, but a new […]